Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on July 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Consumables and Reagent Supply

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
New
DIBBS
Medical Diagnostic Test Kit Manufacturing and PackagingThe contract pertains to the manufacture and packaging of qualitative hCG pregnancy test kits designed to meet stringent diagnostic standards, including specific sensitivity thresholds, minimum shelf-life requirements, and full compliance with labeling regulations. All components must be sourced, assembled, and packaged to ensure consistent performance and regulatory adherence, with strict quality control protocols applied throughout production. The work is to be performed at Fort Bragg, North Carolina, under a subcontract arrangement within the Department of Defense’s Medical Supply Chain network, and all deliverables must align with the technical specifications and compliance expectations set forth by the contracting entity. Bids must be submitted by August 3, 2026, and the NAICS code 325414 indicates this falls under the medical and dental instrument manufacturing sector. The contract is part of a broader effort to ensure reliable, on-demand diagnostic capacity for military and related healthcare operations. While no set-aside status is specified, the project requires full adherence to federal procurement standards for medical devices, including documentation of batch traceability, environmental controls during packaging, and validation testing to confirm accuracy and uniformity across production runs. The kits will be deployed in field medical settings, necessitating durability, clear labeling, and compatibility with existing clinical workflows.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 6 days
NAICS: 325414
New
DIBBS
Medical Supply Packaging and LabelingThe contract entails the packaging and labeling of intravenous administration sets and other medical supplies in strict adherence to federal standards, including ASTM D3951 for packaging and DLA marking requirements for uniform identification and traceability. All work must ensure that products meet rigorous defense and medical logistics specifications to maintain compatibility with military supply chains and operational readiness. The performance location is designated as Waco, Texas, with a zip code of 76707-1019, and the work falls under NAICS code 325414, which classifies it under pharmaceutical and medical preparation manufacturing. This is a subcontract opportunity issued by the Department of Defense under the Medical Supply Chain MD Surg FSF, with proposals required by August 3, 2026. The solicitation is part of an ongoing effort to secure reliable and compliant packaging solutions for critical medical items used by military and healthcare providers. The contract demands precise adherence to labeling and packaging protocols to ensure seamless integration into federal inventory systems and field deployment systems, with no tolerance for noncompliance that could disrupt distribution, inventory control, or patient safety. Participation requires demonstrated experience with DLA standards and the ability to meet strict federal quality and documentation controls.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 6 days
NAICS: 325414
New
Federal
Production of 4,000 Final Lateral Flow StripsThe contract requires the manufacture of 4,000 final lateral flow strips for pre-clinical testing, strictly adhering to a validated design and specifications set by the Centers for Disease Control and Prevention. The work must be performed in compliance with all technical and quality requirements established by the CDC to ensure the strips are suitable for intended pre-clinical use. The project is classified as a subcontract under NAICS code 325414, which corresponds to pharmaceutical and biological product manufacturing, indicating the need for specialized expertise in diagnostic device production. The place of performance is designated as Atlanta, Georgia, with the final deliverables expected to meet CDC’s rigorous standards for accuracy, consistency, and functionality. The solicitation was posted on July 24, 2026, with a response deadline of July 29, 2026, at 7:00 PM Eastern Time, leaving a limited window for qualified vendors to submit proposals. The contracting agency is the CDC Office of Acquisition Services under the Department of Health and Human Services, underscoring the public health significance of the project. While no set-aside provisions or specific organization type requirements are noted, bidders must be prepared to demonstrate capacity, regulatory knowledge, and quality control processes capable of delivering precisely specified diagnostic strips under a tight timeframe. The opportunity is accessible through the SAM.gov platform, and full compliance with CDC guidelines is non-negotiable for contract award.
CDC Office Of Acquisition Services

POSTED

4 days ago

DEADLINE

in 1 day

AI Contract Overview

Show more

The National Institutes of Health, through the Department of Health and Human Services, is seeking a subcontractor to supply recurring plastic consumables and assay kits necessary for the continuous operation of the TapeStation system. This includes essential items such as tapes, reagents, and buffers which are critical for routine laboratory workflows. The solicitation is categorized under NAICS code 325414, indicating a focus on pharmaceutical and biological product manufacturing, and is posted with a response deadline of July 22, 2026. The contract is structured as a subcontract, suggesting it will be awarded to a vendor who will support an existing prime contract or program under the agency's broader research or operational framework. All supplies must meet the technical and quality standards required for reliable performance of the TapeStation platform, and while the place of performance and point of contact details are not specified, the supplier is expected to deliver consistent, reliable shipments to support ongoing scientific activities.

General Info

Supply recurring plastic consumables and assay kits for TapeStation system by July 22, 2026, under NAICS 325414.

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

325414 - Biological Product (except Diagnostic) ManufacturingView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of recurring plastic consumables and assay kits (e.g., tapes, reagents, buffers) required for ongoing operation of the TapeStation system.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 541714
New
Federal
Combines Synopsis Solicitation- iPSC DifferentiatiThe National Institutes of Health, through its Office of the Director and Office of Acquisitions, is seeking to award a firm fixed-price contract on a non-competitive basis to Oxford StemTech Ltd of Oxford, UK, for scientific support services related to the quality control of induced pluripotent stem cells and the generation and characterization of organoids using a subset of these cell lines. This acquisition is conducted under streamlined commercial item procedures outlined in FAR Subpart 12.6 and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603, 41 U.S.C. 1901, and FAR 6.302-3(a)(2)(ii). The solicitation, identified by number 75N98026Q00878, serves as both the notice of intent and the sole solicitation document, eliminating the need for a separate formal request. The contract is classified under NAICS code 541714 and is being procured without competition due to the unique technical capabilities required and the specialized nature of the services. The response deadline for proposals is July 31, 2026, at 6:00 p.m. Eastern Time, with the posting date listed as July 27, 2026. All submissions must be directed to the designated point of contact, John R. Johnson, reachable via email at johnsonjr@mail.nih.gov, with the contract performance to be carried out in Bethesda, Maryland. The contract will be executed under the authority of the Department of Health and Human Services, and no set-asides or small business preferences are applicable. The offering entity, Oxford StemTech Ltd, has been identified as the only qualified source capable of delivering the required services, justifying the non-competitive approach under the specified regulatory exceptions.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 811210
New
Federal
Combines Synopsis Solicitation- Maintenance AgreemThe National Institutes of Health, through the Office of the Director’s Office of Acquisitions, is issuing a non-competitive combined synopsis and solicitation to award a firm fixed-price contract to Hamamatsu for the maintenance, service, and warranty support of NanoZoomer Whole Slide Image Scanners used in NIH laboratories. This acquisition is conducted under FAR Subpart 12.6 and utilizes streamlined procedures for commercial items, with no expectation of exceeding the simplified acquisition threshold. The solicitation does not seek competitive bids and is authorized under FAR 6.302-3(a)(2)(ii) and 41 U.S.C. 1901, allowing for direct award to Hamamatsu based on its unique capability to service this specific equipment. The contract will provide ongoing technical expertise and comprehensive service agreements to ensure uninterrupted operation of the NanoZoomer scanners across NIH facilities. The solicitation number is 75N98026Q00883, and proposals must be submitted by July 31, 2026, at 6:00 p.m. EST. The contract is being managed by the Office of Acquisitions at NIH in Bethesda, Maryland, with Johnson, John R. as the primary point of contact. Although the place of performance is unspecified, the work will support NIH laboratory operations nationwide. The North American Industry Classification System code for this acquisition is 811210, indicating it falls under office machinery and equipment repair and maintenance. There is no set-aside type, and the entire process is designed for expedited non-competitive award based on the singular technical expertise required to maintain the proprietary NanoZoomer scanner systems.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 541713
New
Federal
Oxford Nanopore Technologies promethION 2 integrated long-read sequencerThe contract is for the procurement of an Oxford Nanopore Technologies PromethION 2 integrated long-read sequencer, a next-generation sequencing platform designed to deliver highly informative, real-time genomic and transcriptomic data. Unlike conventional next-generation sequencing technologies, this instrument enables simultaneous whole genome and transcriptome sequencing while detecting base modifications, facilitating unified multi-omics analysis with unprecedented depth and speed. The system is intended for high-impact research applications requiring comprehensive molecular profiling and real-time data integration, positioning it as a critical tool for advanced biological discovery. The solicitation, numbered 75N98026Q00877, was posted by the National Institutes of Health under the Department of Health and Human Services, with the contracting office located in Bethesda, Maryland. The opportunity is classified as a presolicitation with no set-aside designation, and it falls under NAICS code 541713 for research and development in the physical, engineering, and life sciences. The primary point of contact is Vishnuvajjala Hanumanth Rao, reachable via email at vishnuh@mail.nih.gov. Responses are due by August 5, 2026, and performance will be carried out at the agency’s facility in Bethesda, with all equipment to be deployed at the specified location.
Research and Development in Nanotechnology

POSTED

1 day ago

DEADLINE

in 8 days
View Details
NAICS: 325413
New
Federal
Combined Synopsis Solicitation- Acquire 32-sample The National Institutes of Health, through the Department of Health and Human Services, is soliciting proposals under a non-competitive combined synopsis and solicitation for the acquisition of a 32-sample product, identified by solicitation number 75N98026Q00881. This procurement is conducted under FAR Part 12.603 as a streamlined process for commercial items and falls below the simplified acquisition threshold, utilizing statutory authority under 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii) to justify the absence of full and open competition. The solicitation is issued as a Notice of Intent and serves as the only formal request for proposals, with no additional written solicitation to follow. Proposals must be submitted by the deadline of August 3, 2026, at 6:00 p.m. Eastern Time, following the posting date of July 27, 2026. The contracting activity is managed by the Office of Acquisition and Logistics Operations in Bethesda, Maryland, with the NAICS code 325413 indicating the product relates to pharmaceutical and medicine manufacturing. The primary point of contact for inquiries is Cassie M. Runner, reachable via email at cassie.runner@nih.gov or phone at 301-480-8827. The place of performance has not been specified, but the contract award will be directed toward a commercial supplier capable of meeting requirements without competitive bidding, in alignment with the streamlined procedures and statutory exceptions under federal acquisition regulations. All responses must comply with the terms outlined in the combined synopsis, and no further documentation will be issued beyond this notice.
In-Vitro Diagnostic Substance Manufacturing

POSTED

1 day ago

DEADLINE

in 6 days
View Details